Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Context Therapeutics Inc. (CNTX) had Return on Tangible Equity of -5.03% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.58M |
|
-- |
|
-- |
|
$5.53M |
|
$-5.53M |
|
$0.95M |
|
$-4.58M |
|
$-4.58M |
|
$-4.58M |
|
$-4.58M |
|
$-4.58M |
|
$-4.58M |
|
$-5.53M |
|
$-5.53M |
|
95.19M |
|
95.19M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$92.73M |
|
$0.04M |
|
$0.23M |
|
$92.97M |
|
$1.90M |
|
-- |
|
$0.08M |
|
$1.98M |
|
$90.98M |
|
$90.98M |
|
$90.98M |
|
89.70M |
|
| Cash Flow Statement Financials | |
$-5.03M |
|
$-0.03M |
|
$-0.02M |
|
$94.43M |
|
$89.35M |
|
$-5.08M |
|
$0.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
48.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.03% |
|
|
Return on Tangible Equity |
-5.03% |
-4.92% |
|
-5.03% |
|
$1.01 |
|
$-0.05 |
|
$-0.05 |
|